US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

12.39

-0.5900-4.55%

Post-market: 12.36-0.0300-0.24%19:34 EDT

Volume:372.45K

Turnover:4.60M

Market Cap:32.44M

PE:- -

High:12.63

Open:12.48

Low:12.20

Close:12.98

52wk High:36.00

52wk Low:9.23

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.13

T/O Rate:14.23%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug

MT Newswires Live

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live

The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular

Bellwether Stocks Movement

Novo Nordisk (0QIU) Receives a Hold from Barclays

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market

Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity

Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk Foundation to Set Up Quantum Chip Facility

MT Newswires Live

Surge in Crypto ETFs as Hawkish Fed Concerns Ease

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/NVOX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":12.39,"timestamp":1789156800000,"preClose":12.98,"halted":0,"volume":372450,"hourTrading":{"tag":"盘后","latestPrice":12.36,"preClose":12.39,"latestTime":"19:34 EDT","volume":1741,"amount":21555.3422,"timestamp":1789169681481,"change":-0.03,"changeRate":-0.002421,"amplitude":0.003228},"delay":0,"changeRate":-0.04545454545454544,"floatShares":2618100,"shares":2618100,"eps":0,"marketStatus":"Market Closed","change":-0.59,"latestTime":"09-11 16:00:00 EDT","open":12.48,"high":12.625,"low":12.195,"amount":4603397.0814,"amplitude":0.033128,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":12.98,"sharesOutstanding":4098101,"nav":12.96,"aum":33930588.96,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":12.45,"preClose":12.98,"latestTime":"09:23 EDT","volume":24165,"amount":304064.23194,"timestamp":1789132997082,"change":-0.53,"changeRate":-0.040832,"amplitude":0.033128},"postHourTrading":{"tag":"盘后","latestPrice":12.36,"preClose":12.39,"latestTime":"19:34 EDT","volume":1741,"amount":21555.3422,"timestamp":1789169681481,"change":-0.03,"changeRate":-0.002421,"amplitude":0.003228},"volumeRatio":1.128144556689369,"impliedVol":0.6704,"impliedVolPercentile":0.192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2618100,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.128144556689369,"shares":2618100,"dividePrice":0,"high":12.625,"amplitude":0.033128,"preClose":12.98,"low":12.195,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":12.39,"eps":0,"divideRate":0,"volume":372450,"delay":0,"ttmEps":0,"open":12.48,"prevYearClose":21.89,"prevWeekClose":14.57,"prevMonthClose":13.84,"prevQuarterClose":16.05,"fiveDayClose":15.19,"twentyDayClose":14.6,"sixtyDayClose":13.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665532264","title":"Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532264?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:58","pubTimestamp":1788865080,"startTime":"0","endTime":"0","summary":"Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgeryBoomers are the suddenly the fastest-growing customers for cosmetic surgery.Baby boomers are the wealthiest ge","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU2357627491.SGD","LU2089284900.SGD","LU1244550221.USD","VHT","BK4550","LU1093756168.USD","LU1732800096.USD","BK4585","LU0234570918.USD","LU0949170772.SGD","IE00B19Z3B42.SGD","IXJ","SG9999015978.USD","LU0965508806.USD","LU1929549753.HKD","LU0154236417.USD","LU0289961442.SGD","IE00BGHQF631.EUR","LU1989772840.SGD","LU1670627923.USD","LU2324357040.USD","LU0511384066.AUD","LU0795875169.SGD","LU0395794307.EUR","LU0545039389.USD","LU1934455277.USD","LU1732799900.SGD","LU2129689514.USD","BK4588","LU1236620750.USD","LU0203347892.USD","IE000WAW04H5.SGD","RXL","LU1023059063.AUD","LU0124676726.USD","LU0795875086.SGD","LU2129689605.HKD","IE00BN8TJ469.HKD","LU2023251221.USD","IE0002141913.USD","LU2237443465.HKD","LU0058720904.USD","LU1244550494.USD","LU0170899867.USD","LU0320765646.SGD","LU0289739343.SGD","LU0820561818.USD","LU0965509101.SGD","LU1934455194.USD","LU0553294199.USD","LU2125909593.SGD","IE00BDGV0183.EUR","LU2129689431.USD","SG9999015952.SGD","MEDX","PJP","LU0456855351.SGD","NVOH","IE00B3PB1722.GBP","SG9999003800.SGD","IYH","IE00BLSP4452.SGD","LU0432979614.USD","LU1430594728.SGD","OZEM","SG9999011175.SGD","GLAM","LU2089984988.USD","LU1074936037.SGD","SG9999015986.USD","LU1989772923.USD","IE0004445239.USD","LU0029864427.USD","IE00BVYPNW00.USD","LU1923622614.USD","IE00BBT3K403.USD","LU1551013342.USD","LU0726765562.USD","LU1003077747.HKD","THNR","IE0009355771.USD","IE00BJT1NW94.SGD","LU0689472784.USD","LU1061106388.HKD","XLV","LU0985320562.USD","IE00BVYPNV92.GBP","LU0122379950.USD","NVOC","LU1496350502.SGD","IE00B19Z3581.USD","LU1037948541.HKD","LU0861579265.USD","BK4533","LU0198837287.USD","LU0203345920.USD","IE0000B7K699.USD","LU0310799852.SGD","LU0057025933.USD","LU0128525929.USD","LU0859254822.USD","LU1267930490.SGD","LU2133065610.SGD","PPH","IE00B42XCP33.USD","LU0965509010.AUD","LU0965509283.SGD","LU1162221912.USD","LU0943347566.SGD","LU2237443622.USD","LU0310800379.SGD","LU2089283258.USD","LU1585245621.USD","ESTA","LU0738911758.USD","AGNG","IE00BSNM7G36.USD","LU1244550577.SGD","IE000BZT7R73.USD","LU2087621335.USD","LU1093756325.SGD","BK4532","LU0882574055.USD","ABBV","BK4198","BK4581","LU0942090050.USD","LU1551013425.SGD","TRUH","LU1983299246.USD","NVO","LU0158827948.USD","SG9999001440.SGD","LU1291159041.SGD","LU0256863811.USD","IE00B4R5TH58.HKD","LU0211327993.USD","LU0256863902.USD","LU0417517546.SGD","LU0820561909.HKD","LU0098860793.USD","LU0823416689.USD","BK4139","IE0002270589.USD","LU0211328371.USD","LU1267930573.SGD","LU1496350171.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4599","LU0868494708.USD","LU0234572021.USD","BK4559","LU2468319806.SGD","IE000F7OJYX1.SGD","LU2347655156.SGD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU2433249047.HKD","LU0069063385.USD","LU0689626769.HKD","LU0708994859.HKD","BK4566","LU0912757837.SGD","LU1236620834.HKD","LU2237443895.HKD","LU1989771016.USD","IE000MB6IJN5.SGD","LU1037948897.HKD","IE00BZ1G4Q59.USD","BK4007","FHLC","GALDY","IE00BJJMRZ35.SGD","LU0661504455.SGD","LU1839511570.USD","LU2125909247.SGD","LU0472753341.HKD","LU1057294990.SGD","LU0114720955.EUR","LU0868494617.USD","LU2237443549.SGD","FTXH","BK4534","LU2347655073.USD","LU2237443978.SGD","IE000SO60NU8.SGD","LU1718418525.SGD","LU2237443382.USD","LU1934455863.HKD","LU1670628061.USD","NVOX","IE00BKVL7J92.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832664","title":"Novo Nordisk Phase 3 Trial Meets Primary Endpoint for Child Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832664","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832664?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:12","pubTimestamp":1788858753,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Monday its phase 3 Step Young trial evaluating once-weekly semaglutide in children aged six to under 12 with obesity met its primary endpoint.The treatment produced a superior reduction in body mass index at 68 weeks compared with a placebo, the company said.The study also achieved its secondary endpoint for body mass index classification improvement, resulting in 40.4% of treated patients no longer meeting the criteria for obesity, it said.Safety results aligned with previous trials and showed no adverse effects on growth or pubertal development, Novo Nordisk said.Shares of the company were down 1.2% in Tuesday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","OZEM","PPH","NVOX","LU0154236417.USD","LU1093756168.USD","BK4599","NVO","NVOC","LU1093756325.SGD","BK4585","BK4532","THNR","NVOH","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325786","title":"Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325786","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:57","pubTimestamp":1788857878,"startTime":"0","endTime":"0","summary":"Novo Nordisk  has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported Monday.The trials, which tested the drug in heart failure patients, will end early, the company told MT Newswires. It added that patients will continue through to their 3-months follow-up as already planned.Novo said its trial testing ziltivekimab in an acute setting following a heart attack will continue as planned with results expected in H1 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","LU1093756168.USD","NVOX","LU1093756325.SGD","NVO","NVOH","NVOC","IE00BKVL7J92.USD","LU0154236417.USD","OZEM","BK4007","BK4599","THNR","BK4532","IE00BZ1G4Q59.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106138144","title":"The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular","url":"https://stock-news.laohu8.com/highlight/detail?id=1106138144","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106138144?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:29","pubTimestamp":1788852576,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1021.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/1021.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"The Inflammation Bet Unravels: Novo And Novartis Both Stumble In Cardiovascular","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVS","NVOX","NVOC","NVOH"],"isVideo":true,"video":{"duration":72,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1021/render_1021_1788852029273.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1021.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1021/tts/voiceover_9390fdb8b84958e8.mp3","isAI":true},"gpt_icon":0},{"id":"2665328428","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328428?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852330,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK300.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO","IE00BZ1G4Q59.USD","NVOH","PPH","BK4532","LU0154236417.USD","NVOC","THNR","BK4007","OZEM","IE00BKVL7J92.USD","BK4585","NVOX","BK4599","BK4588","LU1093756168.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1093756168.USD","OZEM","NVOX","LU0154236417.USD","LU1093756325.SGD","PPH","BK4007","IE00BKVL7J92.USD","NVOH","THNR","NVO","BK4532","NVOC","BK4585","BK4599","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU2746668974.SGD","LU0868494617.USD","LU0738911758.USD","NVOC","LU1064131342.USD","LU2023250843.SGD","LU0971096721.USD","IE00BFMHRM44.USD","LU1852331112.SGD","LU0417517546.SGD","IE0034235303.USD","FNCL","LU1674673428.USD","LU1261432733.SGD","LU0211327993.USD","LU2357305700.SGD","LU1235294995.USD","BK4554","LU0211328371.USD","IE0004445239.USD","LU1814569148.SGD","LU0106831901.USD","LU0690374961.EUR","IE0002270589.USD","LU1435385759.SGD","SG9999000418.SGD","LU0957791311.USD","LU0170899867.USD","LU0109392836.USD","NVO","JPMO","BK4023","LU0256863811.USD","BK4097","LU0187121727.USD","ORCL","LU0345769128.USD","LU1720051017.SGD","IE00BJTD4V19.USD","LU0130102774.USD","LU2211815571.USD","LU0289960550.SGD","PPH","LU1496350502.SGD","LU2097829019.USD","LU2430703178.SGD","GB00BDT5M118.USD","LU0081259029.USD","LU1823568750.SGD","BK4543","LU0256863902.USD","LU1778281490.HKD","LU0708995401.HKD","IE00BHPRN162.USD","IE00BYQQ9H92.USD","IE00B19Z3B42.SGD","LU0444973449.USD","LU1116320901.HKD","LU1989764748.USD","LU1489326972.SGD","LU1201861249.SGD","LU2125154778.USD","LU2023250504.SGD","LU2756315318.SGD","LU0238689110.USD","LU1691799644.USD","LU2089284900.SGD","IE00BLSP4239.USD","LU1366192091.USD","LU2054465674.USD","LU1551013425.SGD","LU0203345920.USD","SG9999011175.SGD","LU1861214812.USD","LU0289739343.SGD","LU1267930490.SGD","LU2244417387.USD","LU2210150020.SGD","OGIG","LU2095319765.USD","IE0034235295.USD","IE00BYXW3230.USD","LU1989772840.SGD","LU1244550494.USD","LU0557290698.USD","NVOH","LU2264538146.SGD","LU1032466523.USD","LU2087625088.SGD","UBER","LU0965509101.SGD","LU0433182093.SGD","LU1162221912.USD","LU2237443465.HKD","LU1093756168.USD","LU0345769631.USD","BK4532","LU2250418816.HKD","LU0444971666.USD","IE000M9KFDE8.USD","GB00B4LPDJ14.GBP","LU2237443549.SGD","UBRL","LU0965509283.SGD","IE00BJTD4N35.SGD","IE00BKVL7J92.USD","IGV","LU1145028129.USD","LU0949170772.SGD","IE00B1BXHZ80.USD","LU1803068979.SGD","LU1244550221.USD","IE00BK4W5L77.USD","LU0289961442.SGD","SG9999003800.SGD","UYG","LU2543165471.USD","LU2552382215.SGD","BK4588","LU2237438978.USD","LU0672654240.SGD","IE00BMPRXQ63.HKD","LU2168564222.USD","LU1815336760.USD","LU0175139822.USD","SG9999002224.SGD","LU2860962120.EUR","LU0820561909.HKD","LU0106261372.USD","BK4504","LU1983260115.SGD","LU0820561818.USD","BK4536","LU1084165304.USD","ORCZ","FDRV","LU0964807845.USD","IYG","BK4592","LU2168564495.EUR","IE00B7SZLL34.SGD","BK4538","SG9999002232.USD","LU1935043023.USD","OZEM","THNR","LU0211331839.USD","LU2237443895.HKD","SGXZ51526630.SGD","LU0689472784.USD","IE00B19Z9505.USD","LU0496365809.HKD","JPM","IXG","LU1037948897.HKD","TRUF","LU0251132253.USD","LU0648001328.SGD","IE00BDCRKT87.USD","LU1914381329.SGD","IE00BLSP4452.SGD","LU2360032135.SGD","SG9999014914.USD","SG9999015945.SGD","SG9999001424.SGD","LU0965509010.AUD","BK4534","TPOR","LU1917777945.USD","LU1366333091.USD","LU2592432038.USD","BK4528","LU0348723411.USD","LU2213496289.HKD","LU2505996681.GBP","LU0353189763.USD","IE00BZ1G4Q59.USD","SGXZ81514606.USD","TDIV","LU0642271901.SGD","LU2242649171.HKD","IE00BMPRXN33.USD","KBWB","LU1988902786.USD","LU0861579265.USD","BK4550","LU0056508442.USD","LU0234570918.USD","LU0006306889.USD","LU2023250330.USD","IE00BJLML261.HKD","IE00BFXG1179.USD","ADBE","LU1670628061.USD","LU0320765489.SGD","LU0234572021.USD","LU1267930813.SGD","IE00BFXG0V08.USD","LU1670627923.USD","UBEW","ADBG","LU2756315664.SGD","LU1035773651.USD","LU0868494708.USD","SG9999014880.SGD","LU1668664300.SGD","LU0320765059.SGD","LU0976567544.SGD","LU2896262040.SGD","LU2360107325.USD","LU0323591593.USD","LU1934455194.USD","BK4535","LU1674673691.USD","BK4567","LU0690374615.EUR","LU0980610538.SGD","IE00BKDWB100.SGD","BK4230","SGXZ99366536.SGD","LU1935042991.SGD","LU0109391861.USD","NVOX","LU0353189680.USD","LU0342679015.USD","LU0476273544.USD","LU0889565833.HKD","LU2210149790.SGD","LU0345770308.USD","LU1712237335.SGD","LU1506573853.SGD","LU0345770993.USD","SG9999018865.SGD","SG9999015978.USD","LU0943347566.SGD","BK4566","LU0820562030.AUD","BK4007","VFH","LU0640476718.USD","LU0310799852.SGD","LU0208291251.USD","LU1633808545.USD","LU2404859741.USD","LU0942090050.USD","SGXZ31699556.SGD","LU1093756325.SGD","LU0545039389.USD","LU1244550577.SGD","IE00B1XK9C88.USD","LU2326559502.SGD","IE00B19Z3581.USD","LU1037948541.HKD","LU1003077747.HKD","SG9999014898.SGD","LU2458330169.SGD","LU0211326755.USD","LU1894683264.USD","LU1861219969.SGD","LU1069347547.HKD","LU0107464264.USD","LU0203347892.USD","LU2237443622.USD","LU0792757196.USD","JPO","LU1316542783.SGD","IE00BQXX3F31.USD","LU2462157665.USD","IE00BDRTCR15.USD","LU2458330243.SGD","LU0889566641.SGD","ORCS","LU0472753341.HKD","LU2168563687.JPY","LU0149725797.USD","LU0345774631.USD","LU1551013342.USD","LU0683600562.USD","LU0069063385.USD","IE00BN8TJ469.HKD","LU2505996509.AUD","BK4516","LU0210536198.USD","LU2106854487.HKD","LU1989764664.SGD","LU0267386448.USD","IE00BWXC8680.SGD","IE00BQXX3D17.EUR","LU0198837287.USD","LU0154236417.USD","LU0965508806.USD","LU1496350171.SGD","BK4207","LU1934455863.HKD","IE00B3S45H60.SGD","LU1116320737.USD","LU0320765646.SGD","LU2089283258.USD","IE00BBT3K403.USD","BK4585","LU0082616367.USD","LU0314106906.USD","BK4503","LU0265550359.USD","LU1267930730.SGD","LU0985489474.SGD","LU1046421795.USD","LU1935042488.USD","XLF","LU2168564149.EUR","WNDR","SG9999014906.USD","GB00B4QBRK32.GBP","SG9999018857.SGD","LU0265550946.USD","LU0859254822.USD","BK4551","TFNS","ORCU","LU0957808578.USD","BK4022","LU0157215616.USD","LU0511384066.AUD","LU0719512351.SGD","LU0314104364.USD","IE00B5TLWC47.USD","LU0127658192.USD","LU2552382058.USD","LU2430703251.USD","LU1894683348.USD","LU0553294199.USD","IYF","BK4599","LU2125154935.USD","LU1935043536.SGD","IE00BZ199S13.USD","SORCLmain","LU1629891620.HKD","LU2552382132.HKD","LU2746668461.USD","LU2360106780.USD","SG9999015986.USD","LU2417539215.USD","LU0057025933.USD","BK4527","LU1119994496.HKD","IE00BQXX3C00.GBP","IE00BMPRXR70.SGD","ORCX","IE00B5949003.HKD","LU2456880835.USD","SG9999017495.SGD","LU1548497426.USD","LU2404859667.USD","LU1720051108.HKD","BK4581","LU2317271919.USD","LU2357627491.SGD","LU2237443978.SGD","IE0034235188.USD","LU0070302665.USD","LU0661504455.SGD","LU2430703095.HKD","LU0345774391.USD","LU1623119135.USD","BK4533","ORAC","LU1280957306.USD","LU0878866978.SGD","LU1642822529.SGD","LU0787776722.HKD","SG9999015952.SGD","LU1363072403.SGD","LU1429558221.USD","FTXO","IE00B775SV38.USD","IE00BK4W5M84.HKD","LU1934455277.USD","LU1815333072.USD","ADBU","LU0215105999.USD","LU0158827948.USD","LU2236285917.USD","IE0009356076.USD","LU2108987350.USD","LU0048584097.USD","LU0061474960.USD","LU0552385451.USD","LU1989772923.USD","LU2168564065.EUR","BK4505","LU0211326839.USD","LU0882574139.USD","LU1935042215.USD","LU2237957902.USD","LU2237443382.USD","IYT","LU1974910355.USD","LU2237957811.SGD","LU0068578508.USD","LU2023251221.USD","LU2381873111.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVO","IE00BZ1G4Q59.USD","THNR","BK4585","BK4007","NVOC","OZEM","PPH","BK4532","LU1093756168.USD","NVOX","LU0154236417.USD","LU1093756325.SGD","BK4599","BK4588","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756325.SGD","NVO","BK4532","NVOC","IE00BZ1G4Q59.USD","LU0154236417.USD","OZEM","BK4588","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","NVOH","BK4599","NVOX","THNR","BK4585","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731749","title":"Novo Nordisk A/S Series B Stock Flat Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731749","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731749?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:02","pubTimestamp":1788796920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B were flat  at DKK298.95 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.3% to 2,710.84.The stock's rise  snapped a two-day losing streak.The company closed DKK111.00 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 1,797,150, compared to the 50-day average trading volume of 4,122,224.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","BK4007","LU1093756325.SGD","IE00BKVL7J92.USD","THNR","BK4585","PPH","BK4532","BK4599","NVOH","NVO","IE00BZ1G4Q59.USD","BK4588","LU1093756168.USD","OZEM","NVOX","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665131175","title":"Novo Nordisk Stock (NVO) Falls Despite Success in Children’s Weight-Loss Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131175?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:32","pubTimestamp":1788784376,"startTime":"0","endTime":"0","summary":"Novo Nordisk’s ($NVO) shares in Copenhagen edged lower on Monday afternoon. This came even after the Danish pharma giant said in a statement that i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-falls-despite-success-in-childrens-weight-loss-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","NVOC","LU1093756168.USD","NVOH","BK4588","NVO","THNR","BK4532","BK4599","PPH","OZEM","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PINK","IYH","NVOX","THNR","BGIA","NBDS","FHLC","MEDI","RSPH","TRUH","FXH","NVOC","XLVI","NVOH","PJP","CURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319474","title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319474","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319474?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:42","pubTimestamp":1788781356,"startTime":"0","endTime":"0","summary":"Novo scraps two more heart drug trials, further dimming growth beyond obesitySept 7 (Reuters)-Novo NordiskNOVOb.COsaid on Monday it had halted two additional trials of its experimental cardiovascular ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL6N44Z0K2:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novo Scraps Two More Heart Drug Trials, Further Dimming Growth Beyond Obesity","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOH","NVOX","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398326","title":"Clever Culture Systems Wins Expanded Novo Nordisk Order as APAS Nears Global Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398326","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398326?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:23","pubTimestamp":1788740626,"startTime":"0","endTime":"0","summary":"The latest update is out from LBT Innovations Limited ( ($AU:CC5) ). Clever Culture Systems Ltd, an Adelaide-based specialist in AI microbiology au...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clever-culture-systems-wins-expanded-novo-nordisk-order-as-apas-nears-global-validation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756325.SGD","BK4532","NVOC","BK4585","IE00BKVL7J92.USD","PPH","THNR","IE00BZ1G4Q59.USD","NVOH","OZEM","BK4007","BK4588","BK7007","CC5.AU","LU0154236417.USD","LU1093756168.USD","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665835320","title":"Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665835320","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665835320?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:31","pubTimestamp":1788539471,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study A Study Investigating Safety, Tolerability, Pharmacokinetics and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-advances-new-obesity-drug-nnc0721-8060-into-first-human-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4007","IE00BZ1G4Q59.USD","THNR","LU1093756325.SGD","OZEM","NVOX","NVO","NVOH","PPH","LU1093756168.USD","BK4599","LU0154236417.USD","NVOC","BK4532","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665353356","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665353356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665353356?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:02","pubTimestamp":1788537720,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.9% to DKK298.90 Friday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,702.17.This was the stock's second consecutive day of losses.The company closed DKK111.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 3,129,002, compared to the 50-day average trading volume of 4,174,340.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","BK4588","PPH","LU1093756168.USD","BK4599","BK4532","NVOC","IE00BKVL7J92.USD","LU1093756325.SGD","OZEM","LU0154236417.USD","NVO","BK4007","BK4585","NVOX","NVOH","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664533403","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664533403","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664533403?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:00","pubTimestamp":1788526844,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  down 0.3% and the iShares Biotechnology ETF  0.2% lower.Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said. Shares of Novo Nordisk were down more than 1% premarket.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4599","THNR","BK4588","NVO","IE00BKVL7J92.USD","LU0154236417.USD","XBI","BK4581","BK4585","LU1093756168.USD","LU1093756325.SGD","BK4007","BK4532","LABU","PPH","NVOX","OZEM","NVOH","NVOC","XLV","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874873","title":"Novo Nordisk Foundation to Set Up Quantum Chip Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874873","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874873?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:10","pubTimestamp":1788509441,"startTime":"0","endTime":"0","summary":"Novo Nordisk's  charitable foundation and its Quantum Foundry Copenhagen company are planning to set up a new 5,300 square meter quantum chip production facility in Copenhagen, the organizations said Friday.The new plant aims to develop manufacturing equipment for the production of quantum chips.The facility will include laboratory space for nano-fabrication of quantum materials, testing, chip assembly and packaging, along with vacuum manufacturing capabilities, offering wafer fabrication services for customers worldwide, the organizations said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PPH","LU1093756168.USD","NVOX","LU1093756325.SGD","NVO","NVOH","NVOC","IE00BKVL7J92.USD","LU0154236417.USD","OZEM","BK4007","BK4599","THNR","BK4532","IE00BZ1G4Q59.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139354085","title":"Surge in Crypto ETFs as Hawkish Fed Concerns Ease","url":"https://stock-news.laohu8.com/highlight/detail?id=1139354085","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139354085?lang=en_us&edition=fundamental","pubTime":"2026-09-04 14:03","pubTimestamp":1788501803,"startTime":"0","endTime":"0","summary":"Cryptocurrency-linked exchange-traded funds listed in Hong Kong posted sharp gains on Tuesday, tracking a broad rally in digital assets after dovish comments from a Federal Reserve official dampened...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","MNRS","XBTY","BK4516","BTC","LU1861559042.SGD","RGTZ","SH","DMAX","SIMX","BK4539","GCPU","LU1861217088.USD","BTCI","09711","DEFI","LITC","SPUU","STCE","ALA","CBXY","CBOO","DIME","SMAX","CONX","SPXL","IBIT","EZBC","LITU","SBIT","09311","IBLC","ONTX","QBF","CBTJ","CBXJ","BK4596","MVV","SPYH","RGTU","SPYU","ICOI","CONL","CRY","NVTX","BK4535","BK4601","BTCC","COIW","BLCK","BITO","CBTA","BK4585","BK4594","ETTY","LU1861558580.USD","DFII","BCCC","BK4600","CBXO","YBTC","SPYQ","07799","ARKB","LFGY","NVTC","COIO","BK4588","BITW","BITX","SPDN","BKCH","COIX","BFJL","DAPP","GDLC","SPY","LU1861220207.SGD","UPRO","BITU","CBOA","RGTC","CBTO","SPYM","07399","BK4551","CRPT","BK4550","MAXI","BRRR","NBIZ","07711","TXXH","BITB","LU2360107671.USD","NBIL","NVOH","CBOY","BK4554","OSSL","LITX","COYY","BAGY","NVOX","IVV","BETE","FIAT","SPXS","TEUP","BLOK","BLOX","BTCO","BK4082","BK4007","BPI","CBTY","ETNG","LITG","BITI","CONI","LABX","HODL","SAA","SSO","VRC","VRTL","HIBL","XW","NVOC","BTRN","CONY","FINX","YSPY","COII","07311","NEBX","LITZ","BETH","NCIQ","BTCW","BK4112","NBIC","BTCZ","FBTC","SDS","SPXU","FDIG","VOO","BITQ","BTCL","COZX","NBIG","RGYY","FDN","MMAX","BFAP","GBTC","COIG","TEKX","CBOJ","BK4595","HECO","BITY","BTF","RGTX","COIA","CBXA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664848475","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664848475","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664848475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:02","pubTimestamp":1788364920,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 2.6% to DKK301.65 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,678.58.This was the stock's second consecutive day of gains.The company closed DKK108.30 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 4,095,568, compared to the 50-day average trading volume of 4,185,751.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","OZEM","PPH","NVOX","LU0154236417.USD","LU1093756168.USD","BK4599","NVO","NVOC","LU1093756325.SGD","BK4585","BK4532","THNR","NVOH","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}